Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2256 | 4686 | 38.6 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
408 | 3 | CHIM BIOINORGAN//POLO SCI//CARBONIC ANHYDRASE | 29468 |
2256 | 2 | CARBONIC ANHYDRASE//CHIM BIOINORGAN//POLO SCI | 4686 |
2987 | 1 | CHIM BIOINORGAN//CARBONIC ANHYDRASE//POLO SCI | 2093 |
10538 | 1 | CARBONIC ANHYDRASE III//CARBONIC ANHYDRASE//CARBONIC ANHYDRASE VI | 1055 |
11541 | 1 | CARBONIC ANHYDRASE//HUMAN CARBONIC ANHYDRASE II//IMIDAZOLIDINE RING HYDROLYSIS | 974 |
19617 | 1 | SULFATHIAZOLE COMPLEXES//N SUBSTITUTED SULFONAMIDES//SULFONAMIDE LIGANDS | 497 |
37057 | 1 | PRE ANALYTICAL PROCESS//OCCUPAT HLTH PREVENT REINTEGRAT//SCI QUAL HLTH CARE | 67 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CARBONIC ANHYDRASE | authKW | 3393137 | 24% | 47% | 1115 |
2 | CHIM BIOINORGAN | address | 3017117 | 12% | 85% | 547 |
3 | POLO SCI | address | 699429 | 3% | 70% | 153 |
4 | NEUROFARBA | address | 567747 | 4% | 43% | 205 |
5 | CARBONIC ANHYDRASE IX | authKW | 506468 | 3% | 60% | 129 |
6 | SEZ SCI FARMACEUT | address | 491264 | 2% | 93% | 81 |
7 | SEZ SCI FARMACEUT NUTRACEUT | address | 421001 | 2% | 91% | 71 |
8 | DIPARTIMENTO NEUROFARBA | address | 348373 | 1% | 82% | 65 |
9 | SECT PHARMACEUT NUTRICEUT SCI | address | 321027 | 1% | 93% | 53 |
10 | SULFONAMIDES | authKW | 295980 | 7% | 14% | 327 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 22341 | 21% | 0% | 976 |
2 | Biochemistry & Molecular Biology | 5413 | 31% | 0% | 1441 |
3 | Chemistry, Organic | 2085 | 11% | 0% | 515 |
4 | Chemistry, Inorganic & Nuclear | 1627 | 8% | 0% | 356 |
5 | Crystallography | 1501 | 5% | 0% | 255 |
6 | Biophysics | 630 | 5% | 0% | 248 |
7 | Physiology | 512 | 5% | 0% | 216 |
8 | Chemistry, Multidisciplinary | 489 | 10% | 0% | 453 |
9 | Oncology | 254 | 6% | 0% | 283 |
10 | Cell Biology | 189 | 5% | 0% | 254 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHIM BIOINORGAN | 3017117 | 12% | 85% | 547 |
2 | POLO SCI | 699429 | 3% | 70% | 153 |
3 | NEUROFARBA | 567747 | 4% | 43% | 205 |
4 | SEZ SCI FARMACEUT | 491264 | 2% | 93% | 81 |
5 | SEZ SCI FARMACEUT NUTRACEUT | 421001 | 2% | 91% | 71 |
6 | DIPARTIMENTO NEUROFARBA | 348373 | 1% | 82% | 65 |
7 | SECT PHARMACEUT NUTRICEUT SCI | 321027 | 1% | 93% | 53 |
8 | CHIM INORGAN BIOINORGAN | 185638 | 1% | 41% | 69 |
9 | CHIM BIOORGAN | 153584 | 3% | 18% | 128 |
10 | IST BIOSCI BIORISORSE | 125976 | 1% | 54% | 36 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 184934 | 5% | 12% | 235 |
2 | BIOORGANIC & MEDICINAL CHEMISTRY | 18832 | 4% | 2% | 195 |
3 | JOURNAL OF ENZYME INHIBITION | 14295 | 1% | 8% | 28 |
4 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 12691 | 5% | 1% | 224 |
5 | JOURNAL OF MEDICINAL CHEMISTRY | 3563 | 2% | 1% | 111 |
6 | EXPERT OPINION ON THERAPEUTIC PATENTS | 3324 | 1% | 2% | 34 |
7 | REVUE ROUMAINE DE CHIMIE | 3019 | 1% | 1% | 48 |
8 | JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY | 2831 | 1% | 1% | 51 |
9 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 1873 | 1% | 1% | 53 |
10 | BIOCHEMISTRY | 1620 | 3% | 0% | 122 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CARBONIC ANHYDRASE | 3393137 | 24% | 47% | 1115 | Search CARBONIC+ANHYDRASE | Search CARBONIC+ANHYDRASE |
2 | CARBONIC ANHYDRASE IX | 506468 | 3% | 60% | 129 | Search CARBONIC+ANHYDRASE+IX | Search CARBONIC+ANHYDRASE+IX |
3 | SULFONAMIDES | 295980 | 7% | 14% | 327 | Search SULFONAMIDES | Search SULFONAMIDES |
4 | CARBONIC ANHYDRASE INHIBITORS | 178214 | 2% | 35% | 79 | Search CARBONIC+ANHYDRASE+INHIBITORS | Search CARBONIC+ANHYDRASE+INHIBITORS |
5 | HYDRATASE ACTIVITY | 163099 | 1% | 96% | 26 | Search HYDRATASE+ACTIVITY | Search HYDRATASE+ACTIVITY |
6 | BETA CLASS ENZYME | 162860 | 1% | 100% | 25 | Search BETA+CLASS+ENZYME | Search BETA+CLASS+ENZYME |
7 | CA IX | 140367 | 1% | 57% | 38 | Search CA+IX | Search CA+IX |
8 | SULFAMIDE | 116268 | 1% | 54% | 33 | Search SULFAMIDE | Search SULFAMIDE |
9 | CARBONIC ANHYDRASE III | 110075 | 1% | 65% | 26 | Search CARBONIC+ANHYDRASE+III | Search CARBONIC+ANHYDRASE+III |
10 | BETA CARBONIC ANHYDRASE | 104222 | 0% | 80% | 20 | Search BETA+CARBONIC+ANHYDRASE | Search BETA+CARBONIC+ANHYDRASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SUPURAN, CT , (2016) HOW MANY CARBONIC ANHYDRASE INHIBITION MECHANISMS EXIST?.JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. VOL. 31. ISSUE 3. P. 345 -360 | 157 | 96% | 6 |
2 | SUPURAN, CT , DE SIMONE, G , ALTERIO, V , DI FIORE, A , D'AMBROSIO, K , (2012) MULTIPLE BINDING MODES OF INHIBITORS TO CARBONIC ANHYDRASES: HOW TO DESIGN SPECIFIC DRUGS TARGETING 15 DIFFERENT ISOFORMS?.CHEMICAL REVIEWS. VOL. 112. ISSUE 8. P. 4421 -4468 | 216 | 73% | 103 |
3 | KRISHNAMURTHY, VM , KAUFMAN, GK , URBACH, AR , GITLIN, I , GUDIKSEN, KL , WEIBEL, DB , WHITESIDES, GM , (2008) CARBONIC ANHYDRASE AS A MODEL FOR BIOPHYSICAL AND PHYSICAL-ORGANIC STUDIES OF PROTEINS AND PROTEIN-LIGAND BINDING.CHEMICAL REVIEWS. VOL. 108. ISSUE 3. P. 946 -1051 | 314 | 48% | 260 |
4 | SUPURAN, CT , (2017) ADVANCES IN STRUCTURE-BASED DRUG DISCOVERY OF CARBONIC ANHYDRASE INHIBITORS.EXPERT OPINION ON DRUG DISCOVERY. VOL. 12. ISSUE 1. P. 61 -88 | 178 | 96% | 0 |
5 | SUPURAN, CT , (2008) CARBONIC ANHYDRASES: NOVEL THERAPEUTIC APPLICATIONS FOR INHIBITORS AND ACTIVATORS.NATURE REVIEWS DRUG DISCOVERY. VOL. 7. ISSUE 2. P. 168 -181 | 87 | 85% | 607 |
6 | PASTOREK, J , PASTOREKOVA, S , (2015) HYPOXIA-INDUCED CARBONIC ANHYDRASE IX AS A TARGET FOR CANCER THERAPY: FROM BIOLOGY TO CLINICAL USE.SEMINARS IN CANCER BIOLOGY. VOL. 31. ISSUE . P. 52 -64 | 122 | 72% | 27 |
7 | PASTOREKOVA, S , PARKKILA, S , PASTOREK, J , SUPURAN, CT , (2004) CARBONIC ANHYDRASES: CURRENT STATE OF THE ART, THERAPEUTIC APPLICATIONS AND FUTURE PROSPECTS.JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. VOL. 19. ISSUE 3. P. 199-229 | 124 | 84% | 424 |
8 | LINDSKOG, S , (1997) STRUCTURE AND MECHANISM OF CARBONIC ANHYDRASE.PHARMACOLOGY & THERAPEUTICS. VOL. 74. ISSUE 1. P. 1-20 | 138 | 83% | 450 |
9 | MCDONALD, PC , WINUM, JY , SUPURAN, CT , DEDHAR, S , (2012) RECENT DEVELOPMENTS IN TARGETING CARBONIC ANHYDRASE IX FOR CANCER THERAPEUTICS.ONCOTARGET. VOL. 3. ISSUE 1. P. 84-97 | 94 | 88% | 85 |
10 | CAPASSO, C , SUPURAN, CT , (2015) BACTERIAL, FUNGAL AND PROTOZOAN CARBONIC ANHYDRASES AS DRUG TARGETS.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 19. ISSUE 12. P. 1689 -1704 | 123 | 82% | 0 |
Classes with closest relation at Level 2 |